Dr. Reddy's Sees Weight-Loss Drug Boosting Growth After Setback
Dr. Reddy's Laboratories anticipates that its generic weight-loss drug will contribute significantly to growth in the upcoming six-month period ending in March, following resolution of an impurity issue in its key ingredient. The company plans to resume supply of the medication in early November after addressing the manufacturing setback.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- BloombergTrace: Center
Dr. Reddy’s Sees Weight-Loss Drug Boosting Growth After Setback
Dr. Reddy's Laboratories anticipates that its generic weight-loss drug will contribute significantly to growth in the upcoming six-month period ending in March, following resolution of an impurity issue in its key ingredient. The company plans to resume supply of the medication in early November after addressing the manufacturing setback.
Rate outletRead original
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending